drugset / Trial / NCT04794205
Acute Changes In Thermal Pain Response Following Single Oral Dose of Beta-Cary
RandomizedCrossoverQuadruple-blindOther
Summary
Beta-Caryophyllene is an essential oil and cannabis plant derivative also found in edible herbs. It has shown promise as a potential analgesic in preclinical trials. However, there are no human studies characterizing pharmacokinetics of BCP in humans. Therefore, it is of great importance to determine the pharmacokinetics of BCP in humans so that appropriate dosing can be developed for analgesia. This pharmacokinetic work will lay the groundwork for subsequent experiments testing the neural mechanism of BCP on pain.
Timeline
- Start
- 2021-09
- Primary completion
- 2022-04
- Completion
- 2022-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Beta-Caryophyllene | Small molecule | 5 mg | Oral |
| Subject | Beta-Caryophyllene | Small molecule | 30 mg | Oral |
| Subject | Beta-Caryophyllene | Small molecule | 150 mg | Oral |
Indications
No indication recorded.